Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist - Wikidata - awgldk - TriplyDB

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

http://www.wikidata.org/entity/Q35991437

about

Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under development Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis Protection effect of kallistatin on carbon tetrachloride-induced liver fibrosis in rats via antioxidative stress PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.The application of transcriptomic data in the authentication of beef derived from contrasting production systems.Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes.The Antifibrosis Effects of Peroxisome Proliferator-Activated Receptor δ on Rat Corneal Wound Healing after Excimer Laser Keratectomy A new method to isolate and culture rat kupffer cells.Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation.Cell signals influencing hepatic fibrosis Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress.PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically.Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.Pharmacological agents for NASH.Evolving therapies for non-alcoholic steatohepatitis.New therapies for hepatic fibrosis.Dissecting fibrosis: therapeutic insights from the small-molecule toolbox.Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice.New Developments on the Treatment of Liver Fibrosis.Liver inflammation and fibrosis.Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.Novel Anti-fibrotic Therapies.From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions.Intestinal fungi contribute to development of alcoholic liver disease.Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice.Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia.Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus.Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain.Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism.The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis.

P2860

Q26830274-3788FAD3-E74E-4C6B-902D-AD6D86FEED12 Q27021577-31110907-3B87-4D11-86DB-3CA60CF99E31 Q28539856-59F966BE-5342-4E75-A2CF-89BB4A925E92 Q30241952-70F3D272-C7E5-4D1F-AAEB-C0A4B5337924 Q31132226-214850E3-5612-40B9-973D-0E93D002DF26 Q33959032-4646A079-35E1-48D4-8A13-9D3B9DDA605A Q34041838-92A386AA-F430-4B0A-B7B2-23131F71C363 Q34590539-9CC7F7E6-ED90-4734-80BE-C488CC914030 Q34962951-69E7AA16-FC44-4BA9-BC85-53F705373E6E Q35481673-690862EE-98FB-42AB-AC9A-EFEFB6A0C302 Q35569436-C5F888C9-EFB5-4075-8C42-2F73430F8FE1 Q35920984-DBEE72A7-3F26-424E-A188-BE2DFDA5E90C Q36220879-A51EE295-43EC-467F-9FF3-37FA87087AD5 Q36407101-4137CE8E-829D-4BDF-BE4F-99DDEDA8328B Q36459792-EB937182-5C83-4DEA-A3F2-10BE0B8493D9 Q36560010-9F851EB4-6FA0-4553-864A-F305C8A0F0D7 Q36575566-65FC1850-D4C6-4CF6-899A-871E0B4FEF2A Q36733873-0141EE3E-3782-4036-8FA1-E77097270CD6 Q37142522-EEB9EEAA-AE75-4492-A750-1426270148CF Q37613094-12324920-C6E2-4AF1-B809-3E0C8EF5445C Q38089668-30F03EA6-3401-4EC1-AF49-AFBF656DE6BC Q38152646-00AA7A65-B772-4898-8BB3-1F58A4E1CA52 Q38207111-CF592273-36AC-4D48-B229-E54DE4772B5D Q38553309-295A9B14-087F-43D0-B63F-271ACF6A2982 Q38580461-6DA0DB5B-4ACB-43DB-8B37-6BD5C4E3A3A0 Q38698442-22BCFC7E-5202-4491-881A-2EDDEEC324B2 Q38719582-1520D3FA-F9B5-45B6-9DC5-D0A044A17FBA Q38754395-9E854E95-005A-49B1-B3BD-EFC3D1B0E51B Q38873303-1B615EE2-9EF1-4E91-AF70-7C84B0FA7A7D Q39065620-91BDAEC1-049C-4FC8-BF60-92201547875F Q39090639-D91C3360-61C2-44E1-A0F9-BC189C1EC768 Q39377055-BEA09811-C639-46E6-9D95-9AEBAD45E3AE Q39414496-FC557C34-8ABB-4200-B983-497C83B92781 Q41661762-E0B0CA2D-B320-45A1-A248-580AD62D2259 Q41680744-3C386152-0A6F-4365-B35C-BF8DCECD0165 Q42270680-21DAD6C3-1453-40AE-9888-80A9A55FE89E Q42378987-46310A42-DC87-45CE-A6A2-FB55B431B84C Q42417111-63F08E64-D9AE-4DD9-822C-3E1D7D899A2B Q50890478-0096BD88-8012-4167-90DA-051980D84554 Q52699074-30A89B00-63B2-423F-8FA4-F6622AB02BCD

P2860

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

http://www.wikidata.org/entity/Q35991437

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

@ast

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

@en

type

label

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

@ast

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

@en

prefLabel

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

@ast

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

@en

P1433

Q35991437-BDB9B80C-5A4D-4380-99A5-1AC509DCCFCD

P1476

Q35991437-BF77BCED-C278-4AAA-9C25-D957C20D520A

P2093

Q35991437-1CCC1511-0F88-4161-B229-75E784A74E14

Q35991437-50F0D3A3-9AF3-47F4-9E4F-BCC6EA4ADC84

Q35991437-593E267B-DFD6-461D-BB3B-8B38063E624F

Q35991437-6B04BA5F-D0B3-4C27-8A75-33E1717AA206

Q35991437-6B6703FF-E8D0-4631-9F7C-4FE550C2660E

Q35991437-7F41E463-EE1D-4896-9C86-154AD4D461FD

Q35991437-8E6CB3AF-845C-4A62-84FA-FA07947ADAC0

Q35991437-B5BEE21D-72FC-4C5C-BAF4-7001B3A627D5

Q35991437-BD3BE86F-7A2F-4AC4-B523-9DAFD24556AF

P2860

Q35991437-01300C24-3197-48EC-BB4C-A6F68715B090

Q35991437-041530F1-792C-4031-B114-14A94CBF3F13

Q35991437-0B1EAC33-2687-4156-98DE-249E82903537

Q35991437-0DEFF0DF-9765-4F71-A65C-C17A7659CBE2

Q35991437-112FDFDF-AA1A-4496-AFA2-71E31C170C2B

Q35991437-19364D6B-F5BA-4B6B-A594-CE3D81263498

Q35991437-1B210D58-A5CC-4363-A714-652C6443941F

Q35991437-1C152E36-3605-4407-AFEA-E6E4EA3EACE4

Q35991437-27912616-5CDF-4ABE-AB05-CD8600618B4F

Q35991437-343E31DB-3DE6-4685-B315-7E82F4300A70

P304

Q35991437-D86C581E-ECCC-483E-A326-A31C20480E0A

P31

Q35991437-7027E5DF-87EA-4A04-8F2A-8ECD7B032E0D

P356

Q35991437-14F850E7-C279-4F61-8CC3-EC645A1F7FFA

P407

Q35991437-8E1B0048-C210-4BB5-B6F5-2D57CEC667B0

P433

Q35991437-ED91E60D-9004-4550-9B9D-B5BDB42DA079

P478

Q35991437-2CB8F48A-5FBC-4CD6-A439-904037016647

P50

Q35991437-2B0E64B1-8D6D-44F7-B335-4C560C5B371D

Q35991437-7A94141A-2C94-4801-9EA4-99B92DF1D155

Q35991437-8E7B81D1-A7A9-4824-9D04-9902D472147D

P577

Q35991437-BB82F6E9-F106-4DF5-94C0-479AC391F191

P5875

Q35991437-83E48730-8178-42D0-A13C-6BD479CFE016

P698

Q35991437-F154E92E-A50A-4222-8DC1-692954799E0F

P932

Q35991437-36184097-1356-4066-8DB7-DE89427741ED

P356

PNAS.1202464109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

@en

P2093

Bernd Schnabl

http://www.w3.org/2001/XMLSchema#string

Elizabeth Yu

http://www.w3.org/2001/XMLSchema#string

Keiko Iwaisako

http://www.w3.org/2001/XMLSchema#string

Kojiro Taura

http://www.w3.org/2001/XMLSchema#string

Michael Downes

http://www.w3.org/2001/XMLSchema#string

Michael Haimerl

http://www.w3.org/2001/XMLSchema#string

Ruth T Yu

http://www.w3.org/2001/XMLSchema#string

Yong-Han Paik

http://www.w3.org/2001/XMLSchema#string

Yuzo Kodama

http://www.w3.org/2001/XMLSchema#string

P2860

PPARdelta regulates glucose metabolism and insulin sensitivity

PPAR delta: a dagger in the heart of the metabolic syndrome.

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

AMPK and PPARdelta agonists are exercise mimetics

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR

Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome

Macrophages, inflammation, and insulin resistance

Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression

P304

E1369-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1202464109

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Claude B. Sirlin

David A. Brenner

Ronald M. Evans

P577

2012-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224855179

http://www.w3.org/2001/XMLSchema#string

P698

22538808

http://www.w3.org/2001/XMLSchema#string

P932

3361396

http://www.w3.org/2001/XMLSchema#string